The company became the 17th drug manufacture to enter a Most Favored Nation prescription pricing agreement.
President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026. Alex Wong/Getty Images
Regeneron Pharmaceuticals on April 23 became the latest drug manufacturer to enter a Most Favored Nation drug pricing agreement with the United States.
President Donald Trump announced the deal from the Oval Office.
